Screener
Labcorp Holdings LH Ratios & Valuation
| Q2 '26 | Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | ||
|---|---|---|---|---|---|---|
| Profitability | ||||||
| Gross margin | 28.9%+0.7pp | 28.8%+0.9pp | 28.8%+0.9pp | 28.4%+0.5pp | 28.1%+0.1pp | |
| Operating margin | 10.4%+1.6pp | 10.2%+1.9pp | 9.9%+1.6pp | 9.7%— | 8.8%— | |
| Net margin | 7%+1.3pp | 6.7%+1.1pp | 6.3%+0.5pp | 6.2%— | 5.7%— | |
| Returns | ||||||
| Return on equity | 11.7%+2.5pp | 11.1%+2.1pp | 10.5%+1.1pp | 10.1%— | 9.3%— | |
| Return on invested capital | 10.3%+1.0pp | 9.8%+1.5pp | 9.7%+1.4pp | 9.8%— | 9.3%— | |
| Efficiency | ||||||
| Asset turnover | 0.8×0.0× | 0.8×0.0× | 0.8×0.0× | 0.7×0.0× | 0.8×+0.1× | |
| Liquidity | ||||||
| Current ratio | 1.8×+0.3× | 1.7×-0.1× | 1.4×0.0× | 1.6×+0.1× | 1.5×+0.6× | |
| Leverage | ||||||
| Debt-to-equity | 0.8×+0.1× | 0.8×0.0× | 0.8×-0.1× | 0.7×-0.1× | 0.7×+0.2× | |
| Valuation | ||||||
| Market capitalization | $25.01B+14.1% | $21.99B+12.9% | $20.8B+8.4% | $23.85B+26.9% | $21.97B+28.4% | |
| Price / earnings | 25×-3.8× | 23.4×-3.3× | 23.7×-2.0× | 27.9×— | 28.8×— | |
| Price / sales | 1.7×+0.1× | 1.6×+0.1× | 1.5×0.0× | 1.7×+0.3× | 1.6×+0.3× | |
| Price / book | 2.9×+0.3× | 2.5×+0.2× | 2.4×0.0× | 2.7×+0.4× | 2.6×+0.5× | |
| Dividend yield | 0.5%-0.6pp | 1.1%-0.2pp | 1.2%-0.1pp | 1%-0.3pp | 1.1%-0.3pp |
FAQ
- What are Labcorp Holdings's profit margins?
- Labcorp Holdings (LH) runs a 28.9% gross margin and a 10.4% operating margin, with a 7.0% net margin.
- Where do Labcorp Holdings's ratios come from?
- Every ratio is computed from Labcorp Holdings's SEC filings — trailing-twelve-month flows over period-end balances. Valuation multiples combine those fundamentals with market data, recomputed each period. Switch between quarterly, annual, and TTM, or open any ratio for its full history and peer comparisons.
